
|Articles|September 1, 2002
- Applied Clinical Trials-09-01-2002
Using Adaptive Interim Analysis to Calculate Sample Size in a Trial of a Treatment for Erectile Dysfunction
Adaptive interim analysis may allow smaller sample sizes when a drug?s clinical effect is unknown.
Advertisement
Articles in this issue
almost 24 years ago
EU as Physician Rather than Police Officeralmost 24 years ago
Radiology in Oncology Trials: Critical Success Factorsalmost 24 years ago
Changing Current Practicealmost 24 years ago
Coping with the Cost of Prescription Benefitsalmost 24 years ago
EORTC's Regulatory Affairs Unitalmost 24 years ago
Building and Maintaining Monitor-Coordinator Relationshipsalmost 24 years ago
Ethnicity in Drug Development and TherapeuticsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
Bringing the Voice of Clinical Practice and Patients into Drug Development
3
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
4
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
5




